Drug Profile
Tifuvirtide
Alternative Names: R-724; T-1249; TMC-1249Latest Information Update: 06 Aug 2009
Price :
$50
*
At a glance
- Originator Trimeris
- Developer Monogram Biosciences; Roche; Trimeris
- Class Amino acids; Antivirals; Peptides
- Mechanism of Action HIV fusion inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued HIV infections
Most Recent Events
- 09 Sep 2005 ViroLogic is now called Monogram Biosciences
- 06 Jan 2004 Suspended - Phase-I/II for HIV infections in USA (SC)
- 18 Sep 2003 Data presented at the 43rd Annual Meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC-2003) have been added to the adverse events and Viral Infections therapeutic trials section ,